Efficacy and Safety of Enlicitide, an oral PCSK9 Inhibitor, For Lowering LDL Cholesterol in Adults with or At Risk for ASCVD: The Phase 3 CORALREEF Lipids Trial

HIV Articles


Efficacy and Safety of Enlicitide, an oral PCSK9 Inhibitor, For Lowering LDL Cholesterol in Adults with or At Risk for ASCVD: The Phase 3 CORALREEF Lipids Trial

	AHA Nov 7-10 New Orleans

View Older Articles

Back to Top

www.natap.org